Cargando…

Self-stigma and schizophrenia: a cross-sectional study

OBJECTIVE: The aim of this study was to investigate the degree of self-stigma in schizophrenia and its association with clinical and demographic factors. PATIENTS AND METHODS: A total of 197 outpatients (54.3% females) diagnosed with schizophrenia spectrum disorders (schizophrenia, schizoaffective d...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrbova, Kristyna, Prasko, Jan, Holubova, Michaela, Kamaradova, Dana, Ociskova, Marie, Marackova, Marketa, Latalova, Klara, Grambal, Ales, Slepecky, Milos, Zatkova, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127434/
https://www.ncbi.nlm.nih.gov/pubmed/27920538
http://dx.doi.org/10.2147/NDT.S120298
_version_ 1782470245414338560
author Vrbova, Kristyna
Prasko, Jan
Holubova, Michaela
Kamaradova, Dana
Ociskova, Marie
Marackova, Marketa
Latalova, Klara
Grambal, Ales
Slepecky, Milos
Zatkova, Marta
author_facet Vrbova, Kristyna
Prasko, Jan
Holubova, Michaela
Kamaradova, Dana
Ociskova, Marie
Marackova, Marketa
Latalova, Klara
Grambal, Ales
Slepecky, Milos
Zatkova, Marta
author_sort Vrbova, Kristyna
collection PubMed
description OBJECTIVE: The aim of this study was to investigate the degree of self-stigma in schizophrenia and its association with clinical and demographic factors. PATIENTS AND METHODS: A total of 197 outpatients (54.3% females) diagnosed with schizophrenia spectrum disorders (schizophrenia, schizoaffective disorder, delusional disorder) according to International Classification of Diseases – tenth edition participated in the study. The mean age of the patients was 40.10±11.49 years. All individuals completed the Internalized Stigma of Mental Illness (ISMI) scale and a demographic questionnaire. The disorder severity was assessed by both a psychiatrist (the objective version of Clinical Global Impression – severity scale [objCGI-S]) and the patients (the subjective version of Clinical Global Impression – severity scale [subjCGI-S]). Treatment with antipsychotics stabilized the patients. RESULTS: The overall level of self-stigma measured by the total score of the ISMI was 63.32±13.59. The total score of the ISMI positively correlated with the severity of the disorder measured by the objCGI-S and subjCGI-S. In addition, self-stigma positively correlated with the treatment duration and the number of psychiatric hospitalizations. The backward stepwise regression was applied to identify the most significant factors connected to self-stigma. The regression analysis identified the following regressors as the most relevant to self-stigma: the number of previous psychiatric hospitalizations, the severity of the disorder rated by a psychiatrist, and the difference between the objective rating and the subjective rating of the severity of the disorder. CONCLUSION: Outpatients with schizophrenia spectrum disorders, who have undergone a higher number of psychiatric hospitalizations, who dispose of a higher severity of the disorder and show a higher discrepancy between their rating of the severity and the psychiatric rating, showed a greater degree of self-stigma. The management of self-stigma in patients with schizophrenia should be implemented in the routine care.
format Online
Article
Text
id pubmed-5127434
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-51274342016-12-05 Self-stigma and schizophrenia: a cross-sectional study Vrbova, Kristyna Prasko, Jan Holubova, Michaela Kamaradova, Dana Ociskova, Marie Marackova, Marketa Latalova, Klara Grambal, Ales Slepecky, Milos Zatkova, Marta Neuropsychiatr Dis Treat Original Research OBJECTIVE: The aim of this study was to investigate the degree of self-stigma in schizophrenia and its association with clinical and demographic factors. PATIENTS AND METHODS: A total of 197 outpatients (54.3% females) diagnosed with schizophrenia spectrum disorders (schizophrenia, schizoaffective disorder, delusional disorder) according to International Classification of Diseases – tenth edition participated in the study. The mean age of the patients was 40.10±11.49 years. All individuals completed the Internalized Stigma of Mental Illness (ISMI) scale and a demographic questionnaire. The disorder severity was assessed by both a psychiatrist (the objective version of Clinical Global Impression – severity scale [objCGI-S]) and the patients (the subjective version of Clinical Global Impression – severity scale [subjCGI-S]). Treatment with antipsychotics stabilized the patients. RESULTS: The overall level of self-stigma measured by the total score of the ISMI was 63.32±13.59. The total score of the ISMI positively correlated with the severity of the disorder measured by the objCGI-S and subjCGI-S. In addition, self-stigma positively correlated with the treatment duration and the number of psychiatric hospitalizations. The backward stepwise regression was applied to identify the most significant factors connected to self-stigma. The regression analysis identified the following regressors as the most relevant to self-stigma: the number of previous psychiatric hospitalizations, the severity of the disorder rated by a psychiatrist, and the difference between the objective rating and the subjective rating of the severity of the disorder. CONCLUSION: Outpatients with schizophrenia spectrum disorders, who have undergone a higher number of psychiatric hospitalizations, who dispose of a higher severity of the disorder and show a higher discrepancy between their rating of the severity and the psychiatric rating, showed a greater degree of self-stigma. The management of self-stigma in patients with schizophrenia should be implemented in the routine care. Dove Medical Press 2016-11-24 /pmc/articles/PMC5127434/ /pubmed/27920538 http://dx.doi.org/10.2147/NDT.S120298 Text en © 2016 Vrbova et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Vrbova, Kristyna
Prasko, Jan
Holubova, Michaela
Kamaradova, Dana
Ociskova, Marie
Marackova, Marketa
Latalova, Klara
Grambal, Ales
Slepecky, Milos
Zatkova, Marta
Self-stigma and schizophrenia: a cross-sectional study
title Self-stigma and schizophrenia: a cross-sectional study
title_full Self-stigma and schizophrenia: a cross-sectional study
title_fullStr Self-stigma and schizophrenia: a cross-sectional study
title_full_unstemmed Self-stigma and schizophrenia: a cross-sectional study
title_short Self-stigma and schizophrenia: a cross-sectional study
title_sort self-stigma and schizophrenia: a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127434/
https://www.ncbi.nlm.nih.gov/pubmed/27920538
http://dx.doi.org/10.2147/NDT.S120298
work_keys_str_mv AT vrbovakristyna selfstigmaandschizophreniaacrosssectionalstudy
AT praskojan selfstigmaandschizophreniaacrosssectionalstudy
AT holubovamichaela selfstigmaandschizophreniaacrosssectionalstudy
AT kamaradovadana selfstigmaandschizophreniaacrosssectionalstudy
AT ociskovamarie selfstigmaandschizophreniaacrosssectionalstudy
AT marackovamarketa selfstigmaandschizophreniaacrosssectionalstudy
AT latalovaklara selfstigmaandschizophreniaacrosssectionalstudy
AT grambalales selfstigmaandschizophreniaacrosssectionalstudy
AT slepeckymilos selfstigmaandschizophreniaacrosssectionalstudy
AT zatkovamarta selfstigmaandschizophreniaacrosssectionalstudy